نتائج البحث - Sabah Boudjemaa

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    Loss of <scp>RASGRP</scp> 1 in humans impairs T‐cell expansion leading to Epstein‐Barr virus susceptibility

    Loss of <scp>RASGRP</scp> 1 in humans impairs T‐cell expansion leading to Epstein‐Barr virus susceptibility حسب Sarah Winter, Emmanuel Martin, David Boutboul, Christelle Lenoir, Sabah Boudjemaa, Arnaud Petit, Capucine Pïcard, Alain Fischer, Guy Leverger, Sylvain Latour

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study

    Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, an... حسب Christine Mauz‐Körholz, Judith Landman‐Parker, Ana Fernández‐Teijeiro, Andishe Attarbaschi, Walentyna Balwierz, Jörg Bartelt, Auke Beishuizen, Sabah Boudjemaa, Michaela Čepelová, Francesco Ceppi, Alexander Claviez, Stephen Daw, Karin Dieckmann, Alexander Fosså, Stefan Gattenlöhner, Thomas Georgi, Lisa Lyngsie Hjalgrim, Andrea Hrašková, Jonas Karlén, Lars Kurch, Thierry Leblanc, Georg Mann, Françoise Montravers, Jane Pears, Tanja Pelz, Vladan Rajić, Alan D. Ramsay, Dietrich Stoevesandt, Anne Uyttebroeck, Dirk Vordermark, Dieter Körholz, Dirk Hasenclever, William H. Wallace, Regine Kluge

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial

    Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymp... حسب Christine Mauz‐Körholz, Judith Landman‐Parker, Walentyna Balwierz, Roland A. Ammann, Richard A. Anderson, Andishe Attarbaschi, Jörg Bartelt, Auke Beishuizen, Sabah Boudjemaa, Michaela Čepelová, Alexander Claviez, Stephen Daw, Karin Dieckmann, Ana Fernández‐Teijeiro, Alexander Fosså, Stefan Gattenlöhner, Thomas Georgi, Lisa Lyngsie Hjalgrim, Andrea Hrašková, Jonas Karlén, Regine Kluge, Lars Kurch, T. J. LEBLANC, Georg Mann, Françoise Montravers, Jean Pears, Tanja Pelz, Vladan Rajić, Alan D. Ramsay, Dietrich Stoevesandt, Anne Uyttebroeck, Dirk Vordermark, Dieter Körholz, Dirk Hasenclever, William H. Wallace

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Molecular and clinicopathologic characterization of pediatric histiocytoses

    Molecular and clinicopathologic characterization of pediatric histiocytoses حسب Zofia Hélias‐Rodzewicz, Jean Donadieu, Nathalie Terrones, Mohamed‐Aziz Barkaoui, Anne Lambilliotte, Despina Moshous, Caroline Thomas, Saba Azarnoush, Marlène Pasquet, L Mansuy, Nathalie Aladjidi, Éric Jeziorski, Perrine Marec‐Bérard, Marion Gilibert‐Yvert, Alexandra Spiegel, Paul Saultier, Isabelle Pellier, Anne Pagnier, Sophie Pertuisel, Maryline Poirée, Damien Bodet, Frédéric Millot, Florentina Isfan, Jean-Louis Stéphan, Amaury Leruste, Charlotte Rigaud, Bruno Filhon, Liana Carausu, Yves Réguerre, Isabelle Kieffer, Bénédicte Brichard, Rim Ben Jannet, Mariama Bakari, Ahmed Idbaïh, Christine Bodemer, F. Cohen Aubart, Julien Haroche, Abdellatif Tazi, Sabah Boudjemaa, Sylvie Fraitag, Jean‐François Emile, Sébastien Héritier

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    <i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

    <i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy حسب Sebastien Héritier, Jean‐François Emile, Mohamed‐Aziz Barkaoui, Caroline Thomas, Sylvie Fraitag, Sabah Boudjemaa, Florence Renaud, Philippe Moreau, Michel Peuchmaur, Catherine Chassagne‐Clément, Frédérique Dijoud, Valérie Rigau, Despina Moshous, Anne Lambilliotte, Françoise Mazingue, Kamila Kébaïli, Jean Miron, Éric Jeziorski, Geneviève Plat, Nathalie Aladjidi, Alina Ferster, Hélène Pacquement, Claire Galambrun, Laurence Brugières, Guy Leverger, L Mansuy, Catherine Paillard, Anne Deville, Corinne Armari‐Alla, Anne Lutun, Marion Gillibert‐Yvert, Jean‐Louis Stéphan, F. Cohen Aubart, Julien Haroche, Isabelle Pellier, Frédéric Millot, Brigitte Lescoeur, Virginie Gandemer, Christine Bodemer, Roger Lacave, Zofia Hélias‐Rodzewicz, Valérie Taly, Frédéric Geissmann, Jean Donadieu

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: